PMV Pharmaceuticals to Present at Evercore ISI 3rd Annual HealthCONx Conference

Rhea-AI Summary

PMV Pharmaceuticals (Nasdaq: PMVP) has announced that CEO David H. Mack, Ph.D., will present at the Evercore ISI 3rd Annual HealthCONx Conference on December 2, 2020, at 1:00 PM ET. This presentation focuses on the company's pioneering work in precision oncology, targeting p53 mutants, a common mutation in cancer. Interested parties can access the presentation via the company's website. PMV Pharma, based in Cranbury, New Jersey, specializes in tumor-agnostic therapies and is leveraging decades of research in p53 biology.

CRANBURY, N.J., Nov. 24, 2020 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53 mutants, today announced that David H. Mack, Ph.D., President and Chief Executive Officer, will present on Wednesday, December 2, 2020 at the Evercore ISI 3^rd Annual HealthCONx Conference. The presentation will also be available on PMV’s web site. Details on the presentation can be found below.

Evercore ISI 3^rd Annual HealthCONx Conference

Date:	Wednesday, December 2, 2020
Time:	1:00 PM ET
Webcast:	https://wsw.com/webcast/evercore11/pmvp/2394615

About PMV Pharma

PMV Pharma is a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53 mutants. p53 is mutated in approximately half of all cancer. The field of p53 biology was established by our co-founder Dr. Arnold Levine when he discovered the p53 protein in 1979. Bringing together leaders in the field to utilize over four decades of p53 biology, PMV Pharma combines unique biological understanding with pharmaceutical development focus. PMV Pharma is headquartered in Cranbury, New Jersey. For more information, please visit www.pmvpharma.com.

Contacts

For Investors:
Winston Kung
Chief Financial Officer
investors@pmvpharma.com

For Media:
Mariann Caprino
mcaprino@pmvpharma.com
(917) 242-1087

 

FAQ

When is PMV Pharmaceuticals' presentation at the Evercore ISI 3rd Annual HealthCONx Conference?

PMV Pharmaceuticals' presentation is on December 2, 2020, at 1:00 PM ET.

Who is presenting for PMV Pharmaceuticals at the Evercore ISI conference?

David H. Mack, Ph.D., President and CEO of PMV Pharmaceuticals, will present.

What is the focus of PMV Pharmaceuticals' presentation?

The presentation focuses on the company's work in precision oncology targeting p53 mutants.

Where can I access the PMV Pharmaceuticals presentation?

The presentation will be available on PMV Pharmaceuticals' website.

What is the significance of targeting p53 mutants in cancer?

Targeting p53 mutants is significant as p53 mutations occur in approximately half of all cancers.